Lymphoma: all 5,623 studies
Page 6 of 57. Open to participants first (823), then studies with results posted, then the rest; newest registration first within each.
- the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in LymphomaNot yet recruitingNCT05834751Not applicable
- Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis BiomarkersNot yet recruitingNCT05834426
- Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell LymphomaRecruitingNCT05833893Phase 2
- A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.RecruitingNCT05833763Phase 2
- Frontline of ASCT in High-risk DLBCLRecruitingNCT05831865
- CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers StudyRecruitingNCT05828628
- Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell LymphomaRecruitingNCT05826535Phase 1/2
- Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 TrialRecruitingNCT05816850
- Decitabine and Anti-PD-1 in R/R DLBCLRecruitingNCT05816746Phase 2
- A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell LymphomaNot yet recruitingNCT05814848Phase 4
- Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell LymphomaRecruitingNCT05806580Phase 4
- A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHLRecruitingNCT05806099Phase 1/2
- Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's LymphomaRecruitingNCT05805943Phase 1/2
- Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.RecruitingNCT05803395
- A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell LymphomaRecruitingNCT05800366Phase 2
- Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory LymphomaRecruitingNCT05798897Phase 1
- Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX51 in Patients With Solid Tumor or LymphomaNot yet recruitingNCT05788107Phase 1
- A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell LymphomasRecruitingNCT05773040Phase 1
- A Clinical Study of Injectable IMM0306 in Combination With LenalidomideNot yet recruitingNCT05771883Phase 1/2
- DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive CancersRecruitingNCT05770037Phase 2/3
- Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin LymphomaRecruitingNCT05757466Phase 2
- Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or LymphomasRecruitingNCT05751798Phase 1/2
- Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA)Not yet recruitingNCT05746858
- Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and CareRecruitingNCT05745285Not applicable
- Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic LymphomaRecruitingNCT05745181Phase 2
- Assessing the Presence of CT-DNA in Lymphoma Associated HLHRecruitingNCT05702502
- Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBLRecruitingNCT05694312Phase 2
- ThisCART19A for B-NHL Relapsed After Auto-CAR TRecruitingNCT05691153Phase 1
- Chidamide in Patients With Recurrent and Refractory Diffuse Large bEnrolling by invitationNCT05690191
- EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ DiseasesNot yet recruitingNCT05688241Phase 1/2
- Phase 2 Multi-center Randomized Study to the Efficacy and Safety of AK105 Combined With Anrotinib Hydrochloride in Patients With Recurrent/Refractory Classical Hodgkin's LymphomaEnrolling by invitationNCT05683704Phase 2
- Clinical Study of Improved BEAM Conditioning Regimen for ASCT in LymphomaNot yet recruitingNCT05681403Not applicable
- AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFHEnrolling by invitationNCT05678933Phase 3
- Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in TexasRecruitingNCT05676450Not applicable
- Genotype-guided Treatment in Newly Diagnosed PTCLRecruitingNCT05675813Phase 1/2
- Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin LymphomaRecruitingNCT05667155Phase 1
- Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related CancersRecruitingNCT05663502
- PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell LymphomaRecruitingNCT05662540Not applicable
- CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCLRecruitingNCT05659628Phase 1
- Safety and Efficacy of Sequential CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell LymphomaNot yet recruitingNCT05651100Phase 1/2
- TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid TumorsRecruitingNCT05650580Phase 1
- CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility ProtocolRecruitingNCT05648019Phase 2
- Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular TherapyRecruitingNCT05646576Not applicable
- A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell MalignanciesRecruitingNCT05643742Phase 1/2
- Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell LymphomaRecruitingNCT05635162Phase 2
- TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHLRecruitingNCT05631912Phase 1/2
- Combination of CAR-DC Vaccine and ICIs in Malignant TumorsRecruitingNCT05631886Phase 1
- Response Adapted Incorporation of Tislelizumab Into the Front-line Treatment of Older Patients With Hodgkin lYmphomaNot yet recruitingNCT05627115Phase 2
- Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBLRecruitingNCT05626400Not applicable
- CD7 CAR-T Cells in T-cell Lymphoma/LeukemiaRecruitingNCT05620680Not applicable
- The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological MalignanciesRecruitingNCT05618041Not applicable
- Long-term Ovarian Fertility in Patients Treated for Lymphoma.RecruitingNCT05616325
- First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory LymphomaRecruitingNCT05607498Phase 1
- Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System LymphomaRecruitingNCT05600660Phase 2
- Modified TBF Regimen as Conditioning Regimen Prior to Allo-HSCT for T-ALL/LBLRecruitingNCT05598593Phase 2
- Treatment Strategy for Relapsed/Refractory Hodgkin LymphomaRecruitingNCT05595447Phase 2/3
- Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell LymphomaRecruitingNCT05590221Phase 2
- Exploratory Clinical Study of CD19-targeted CAR-T and CAR-DC in the Treatment of Relapsed and Refractory B-cell LymphomaRecruitingNCT05585996Phase 1
- Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/LeukemiaRecruitingNCT05576532Phase 2
- Mitoxantrone Hydrochloride Liposome Combined With Rituximab and Lenalidomide (M+R2) in Patients With Relapsed and Refractory Diffuse Large B-Cell LymphomaNot yet recruitingNCT05575973Phase 2
- Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell PhenotypeRecruitingNCT05572983Phase 2
- PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow Infiltration for Initial Staging of LymphomaNot yet recruitingNCT05565898
- A Umbrella Study in R/R PTCL Guided by Molecular SubtypesRecruitingNCT05559008Phase 1/2
- A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous TransplantationNot yet recruitingNCT05545202Phase 4
- Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic MalignanciesRecruitingNCT05544968Phase 1
- Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte MalignanciesRecruitingNCT05541341
- Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib BloodlevelsRecruitingNCT05525338Phase 4
- TreAtments and outComes in paTients With prImary CutAneous LymphomaRecruitingNCT05518851
- B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021RecruitingNCT05518383Phase 4
- GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL)Not yet recruitingNCT05518318Phase 3
- A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell LymphomaRecruitingNCT05506410
- Zanubrutinib-rituximab(ZR) in Patients With Newly Diagnosed Untreated Mantle Cell LymphomaRecruitingNCT05504603Phase 2
- Orelabrutinib Therapy in Patients With r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase InhibitorsRecruitingNCT05495828
- Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell MalignanciesRecruitingNCT05487651Phase 1
- Zanubrutinib in the Treatment of Recurrent Refractory Mantle Cell LymphomaRecruitingNCT05486013
- Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal TypeRecruitingNCT05477264Phase 2
- Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic MalignanciesRecruitingNCT05476770Phase 1
- A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic LymphomasRecruitingNCT05475925Phase 1/2
- ChiCGB vs BEAM in High-risk or R/R LymphomasRecruitingNCT05466318Phase 3
- A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell TherapyRecruitingNCT05464719Phase 2
- CMOEP in the Treatment of Untreated Peripheral T-cell LymphomaNot yet recruitingNCT05458180Phase 1
- Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHLRecruitingNCT05453669Phase 1
- Transplantation After Complete Response In Patients With T-cell LymphomaRecruitingNCT05444712Not applicable
- Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)RecruitingNCT05444348Not applicable
- A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin LymphomaRecruitingNCT05444322Early Phase 1
- CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell MalignanciesRecruitingNCT05442515Phase 1/2
- Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCLRecruitingNCT05441761Phase 1/2
- Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's LymphomaRecruitingNCT05436223Phase 2
- The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma.RecruitingNCT05428670Phase 2
- The Whole-course Management of Pegaspargase in ENKTLNot yet recruitingNCT05426824Not applicable
- Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin LymphomaRecruitingNCT05420493Phase 1
- Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasRecruitingNCT05415098Phase 1
- Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)RecruitingNCT05403177
- Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ MalignanciesRecruitingNCT05391490Phase 1
- Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSLRecruitingNCT05390749Phase 2
- A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular LymphomaRecruitingNCT05389293Phase 2
- A Mixed Methods Study of Nutrition Practice in Cancer Care on Non-Hodgkin Lymphoma PopulationRecruitingNCT05376709Not applicable
- Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)RecruitingNCT05371132Phase 1
- Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell LymphomaRecruitingNCT05367856Phase 2
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruitingNCT05366881